Cargando…

Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study

The 2018 International Federation of Gynecology and Obstetrics (FIGO) revision to the staging criteria for uterine cervical cancer adopted pathological staging for patients who underwent surgery. We investigated the correlation between clinicopathological factors and prognosis in patients with high-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shigeta, Shogo, Shimada, Muneaki, Tsuji, Keita, Watanabe, Zen, Tanase, Yasuhito, Matsuo, Koji, Nakanishi, Toru, Saito, Toshiaki, Aoki, Daisuke, Mikami, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368631/ https://www.ncbi.nlm.nih.gov/pubmed/37491468 http://dx.doi.org/10.1038/s41598-023-39014-8

Ejemplares similares

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
por: Berek, Jonathan S., et al.
Publicado: (2018)

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan
por: Matsuo, Koji, et al.
Publicado: (2017)

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
por: Machida, Hiroko, et al.
Publicado: (2022)

Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2021)

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
por: Matsuo, Koji, et al.
Publicado: (2019)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents
por: Oyama, Yoshiko, et al.
Publicado: (2021)

자궁경부암: 개정된 2018 FIGO 병기와 자기공명영상을 중심으로
Publicado: (2021)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009
por: Zhang, Yunqiang, et al.
Publicado: (2022)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
por: Tomizawa, Kento, et al.
Publicado: (2020)

Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Reconsideration of Sharp Dissection in Gynecological Surgery
por: Tanase, Yasuhito, et al.
Publicado: (2023)

Imaging in Carcinoma Cervix and Revised 2018 FIGO Staging System: Implications in Radiology Reporting
por: Dhamija, Ekta, et al.
Publicado: (2021)

Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
por: Chen, Xiaolin, et al.
Publicado: (2022)

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)

An Attempt to Develop a New Treatment Strategy for Rare Refractory Gynecological Malignancies: The Japanese Gynecologic Oncology Group
por: Shigeta, Shogo, et al.
Publicado: (2023)

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2019)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors
por: Yan, Ding-Ding, et al.
Publicado: (2019)

Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review
por: Qin, Fengying, et al.
Publicado: (2022)

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
por: Ikeda, Masae, et al.
Publicado: (2021)

Precautions during Direct Oral Anticoagulant Introduction in Gynecologic Malignancies: A Single-Center Retrospective Cohort Study
por: Shimizu, Takanori, et al.
Publicado: (2023)

Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer
por: Zhang, Xuewei, et al.
Publicado: (2020)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
por: Li, Zhiqiang, et al.
Publicado: (2022)

Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer
por: Wagner-Larsen, Kari S., et al.
Publicado: (2022)

Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer
por: Hishinuma, Eiji, et al.
Publicado: (2021)

FIGO Award for Professor Marleen Temmerman
por: Vergote, I.
Publicado: (2009)

The FIGO Ovulatory Disorders Classification System
por: Munro, Malcolm G, et al.
Publicado: (2022)

The FIGO ovulatory disorders classification system
por: Munro, Malcolm G., et al.
Publicado: (2022)

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021)

Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage
por: Balaya, Vincent, et al.
Publicado: (2020)

Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
por: Meng, Qingyu, et al.
Publicado: (2022)

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter
por: Nicolai, Laure, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mrvrv168mnskjgthe6av3vjajb